Searched for
BULK DRUGS AND FORMULATIONS
Virtual pharma API firm HRV preparing for IPO, DRHP likely in H1 of 2027: SourcesHRV Pharma CEO Hari Kiran Chereddi says investing in capacity at partner facilities, exploring acquisitions for market access; forecasts Rs...- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsAs an investor, what you need to do at this point of time is this: A bit of extra work in terms of stock-picking so that you avoid anxiety ...
- Chemical sector: Although long, there is a way around China trouble; combine 20 stocks to get your portfolio’s chemistry rightFor the chemicals sector, it all depends on a transformation that is still unfolding and will take years to play out. Backward-integration ...
- Swadeshi 1.0 vs. Made in India 2.0: How India turned a 1905 boycott into a 2026 business strategyIndependence Day 2026: From the Swadeshi movement to Atmanirbhar Bharat. Early Swadeshi movements fostered indigenous industries against im...
- Drug formulations & biologicals keep India's pharma exports healthy in Q1During the first quarter of fiscal 2027, India's pharmaceutical exports soared to $8.10 billion, showcasing remarkable strength in drug for...
- Nutraceuticals, get it right from the startThe Indian supplements market is anticipated to soar to nearly fifty-seven billion dollars by twenty thirty, driven by heightened consumer ...
- Pharma exports to UK may rise up to 10% in FY27 as CETA takes effectIndia's pharmaceutical exports to the UK are set to witness substantial growth thanks to the recently negotiated Comprehensive Economic and...
- India-UK FTA projected to boost Indian pharma exports by over 8% to $981 million in FY27: PharmexcilIndian pharmaceutical exports to the United Kingdom are projected to grow significantly. The India-UK Comprehensive Economic and Trade Agre...
- No shortage of APIs and formulations in the country: GovtNPPA has informed that it has not received any reference from pharma associations regarding steep increase in price of medicines due to out...
- Govt taking steps to reduce country's dependence on imports of antibiotic raw materialsAs per the information received from the port offices of the Central Drugs Standard Control Organisation (CDSCO), it stood at 12,006.11 met...
- NPPA fixes retail price of 30 drug formulationsThe National Pharmaceutical Pricing Authority (NPPA) has also revised the prices of three formulations, including that of anti cancer drug ...
- NPPA fixes price of 39 drug formulation packsAs per the notification the prices of formulations including Ciprofloxacin Hydrochloride, Cefotaxime, Paracetamol, Domperidone and Metformi...
- Government to formulate policy to promote bulk drug manufacturingThe recommendations are being examined for formulation of a policy for promotion of manufacturing of bulk drugs.
- Government caps prices of 52 more "essential" drugs, including painkillers & antibioticsThese drugs include commonly-used antibiotics and painkillers as well as medicines used for treating cancer and skin disorders.
- Indian pharmaceutical exports to cross Rs 1 lakh crore markExport of pharmaceutical products from India are set to cross Rs 1 lakh crore mark this fiscal from Rs 90,000 crore during fiscal .
- Pharma companies told to reveal quarterly drug dataThe drug price regulator has asked pharmaceutical companies to disclose quarterly data on the amount of essential drugs they are producing.
- Alembic Pharma’s net profit 27 pc up; to abandon low margin API & formulationVadodara-based drug maker, Alembic Pharmaceuticals Ltd registered annual net profit rise of 27% largely due to domestic business.
- Drugs likely to cost more after hike in excise dutyDrugs are expected to cost more due to hike in excise duty to 6% from 5% on formulations and to 12% from 10% on bulk drugs announced by FM ...
- Higher prices for 70 drugsThe government may agree to price increases in 70 scheduled drugs and revise those of several bulk drugs.
- Panel’s suggestion on low cost drugs okayedNEW DELHI: The Pharmaceutical Policy, 2002, has accepted the Drug Price Control Review Committee's suggestion that low-cost drugs measured ...
Load More
